Discrepancies in patients' medication lists from pharmacies in Sweden: an interview study before the implementation of the Swedish National Medication List

被引:5
|
作者
Hammar, Tora [1 ]
Mzil, Leila [2 ]
Eiermann, Birgit [3 ,4 ]
机构
[1] Linnaeus Univ, Fac Hlth & Life Sci, eHlth Inst, Dept Med & Optometry, Kalmar, Sweden
[2] Uppsala Univ, Fac Pharm, Dept Pharmaceut Biosci, Div Pharmacokinet & Drug Therapy, Uppsala, Sweden
[3] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden
[4] Inera AB, Swedish Assoc Local Author & Reg, Stockholm, Sweden
关键词
Medication list; Electronic prescribing; Medication error; Medication reconciliation; Drug-related problems; Pharmacy; INFORMATION; SYSTEMS; CARE;
D O I
10.1007/s11096-022-01480-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Discrepancies in medication lists are common and can contribute to drug-related problems. This study was performed before the implementation of the National Medication List in Sweden, an intervention expected to improve the accuracy of medication lists. Aim The aim of the study was to examine the number and type of discrepancies in the medication list from pharmacies in Sweden. The secondary aim was to describe the information sources Swedish patients used as their medication lists and how confident they were with the information. Method Structured interviews were conducted with patients at 13 community pharmacies in Sweden during the period October 5, 2020, to April 16, 2021. The printed medication list was reviewed together with the patient to identify any discrepancies and missing information. Results A total of 327 patients were included in the study (response rate 51%). The printed medication list from pharmacies was the most common information source for patients to know which medications to use. Two thirds (n = 215) of the patients had at least one discrepancy among their prescriptions and 32% (n = 106) were missing at least one prescription medication. Among all prescriptions (n = 2567) 10% (n = 264) were non-current prescriptions, 9% (n = 238) were duplicates and 3% (n = 88) had the wrong dose. The proportion of prescriptions with discrepancies differed between drug-groups. Conclusion The discrepancies described in this study can have serious consequences, and results provide a baseline for studies after the implementation of the National Medication List.
引用
收藏
页码:88 / 96
页数:9
相关论文
共 24 条
  • [21] Implementation of Telepharmacy to Provide Medication Consultation Service for Patients: A Case Study From Thu Duc City Hospital, Ho Chi Minh City
    Van Dat, Truong
    Minh, Nguyen Hong
    Hoang, Thai Minh
    Hien, Tran Thu
    Bao, Phan Nguyen Hoai
    Tu, Vo Linh
    Hung, Nguyen Vu
    Thuy, Nguyen Huu Lac
    Nga, Dang Thi Kieu
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [22] Predictors of diabetes medication utilization and health care costs in US patients with Type-2 diabetes: Results from a national survey study
    Shenolikar, R
    Balkrishnan, R
    VALUE IN HEALTH, 2005, 8 (06) : A168 - A169
  • [23] Physician experiences when discussing the need for additional oral medication with type 2 diabetes patients: Insights from the cross-national IntroDia® study
    Down, Susan
    Alzaid, Aus
    Polonsky, William H.
    Belton, Anne
    Edelman, Steven
    Gamerman, Victoria
    Nagel, Friederike
    Lee, Jisoo
    Emmerson, James
    Capehorn, Matthew
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 148 : 179 - 188
  • [24] Physicians' Challenges When Discussing the Need for Additional Oral Medication with Type 2 Diabetes (T2D) Patients: Insights from a Cross-National Study (IntroDia™)
    Capehorn, Matthew
    Belton, Anne
    Down, Susan
    Gamerman, Victoria
    Nagel, Friederike
    Lee, Jisoo
    Clark, Douglas
    Edelman, Steven
    Polonsky, William H.
    DIABETES, 2015, 64 : A226 - A226